Could a more coordinated EU HTA improve access to new healthcare technologies, favour development of EU-wide evidence development infrastructure and reduce fragmentation? These and other related topics will be discussed on July 9th in Brussels in a meeting organised by the EU Commission and that will involve relevant stakeholders. Here below a link to the meeting webpage:

meeting programme


Previous PostNext Post